Previous 10 | Next 10 |
Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division PR Newswire Division Combines Oyster Point Pharma's Eye Care Expertise with Famy Life Science's Phase III-ready Pipeline and Lays Foundation for Viatris to Bec...
Summary DON is a mid-cap dividend ETF with a monthly distribution. Financials represent 24% of asset value. Valuation and quality metrics look a bit better than the S&P Midcap 400. Historical performance is close to the mid-cap benchmark. This dividend ETF article ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the healthcare sector poised to grow significantly in the coming years, healthcare stocks to buy present a fantastic opportunity for investors. Healthcare is something that everyone will need at some point in their lives, ...
Eli Lilly 's (NYSE: LLY) biosimilar drug known as Rezvoglar was given the green light by the U.S. Food and Drug Administration (FDA) to be marketed as an interchangeable to Sanofi 's (NASDAQ: SNY) Lantus long-acting insulin. This follows the FDA's approval of Rezvoglar as a biosimil...
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors PR Newswire Directors Neil Dimick and Ian Read Retire PITTSBURGH , Dec. 29, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global he...
Bargain hunting for inexpensive dividend stocks is a good habit if you're trying to build a passive income stream from your investments. If you have the wherewithal to buy shares of companies that have taken a beating during the latest bear market, procuring stocks while their prices are lower th...
Dividend hikes aren't automatic, but they can sometimes be predictable. As long as a company is doing well and an increase to the dividend looks probable, the timing of the announcement often will come at around the same time as it did in the previous year. Three stocks that I expect will ann...
Viatris Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference PR Newswire PITTSBURGH , Dec. 23, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the 41 st Annual ...
Viatris Announces Donations Totaling $1 Million to Provide Aid Supporting Access to Healthcare, Food Security and Water Stewardship PR Newswire The contribution includes donations to four organizations: Direct Relief, World Central Kitchen, WaterAid and World Food Program US...
Viatris Announces Approval of Emissions Reduction Targets by the Science Based Target initiative (SBTi) PR Newswire PITTSBURGH , Dec. 14, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that its near-term sci...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...